Here are six quick facts about the transaction:
1. Mr. Lucier purchased 10,000 NuVasive shares.
2. The shares were purchased at $49.71 per share.
3. The total transaction reached $497,100.
4. Company shares rallied 41.61 percent from the one-year high price.
5. Company insiders hold 1.54 percent of shares and institutions hold 99 percent of shares.
6. NuVasive’s market cap is $2.3 billion.
More articles on orthopedic devices:
10 trends to note in the knee implant market
8 trends in the North American neurosurgery market
5 predictions about the 2012-2018 bio-implant market
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
